AREG, amphiregulin, 374

N. diseases: 221; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.010 AlteredExpression disease BEFREE Upregulation of amphiregulin by retinoic acid and Wnt signalling promotes liver cancer cell proliferation. 31298420 2020
Liver and Intrahepatic Biliary Tract Carcinoma
0.010 AlteredExpression disease BEFREE Upregulation of amphiregulin by retinoic acid and Wnt signalling promotes liver cancer cell proliferation. 31298420 2020
CUI: C0345904
Disease: Malignant neoplasm of liver
Malignant neoplasm of liver
0.010 AlteredExpression disease BEFREE Upregulation of amphiregulin by retinoic acid and Wnt signalling promotes liver cancer cell proliferation. 31298420 2020
CUI: C0004114
Disease: Astrocytoma
Astrocytoma
0.010 Biomarker disease BEFREE Kaplan-Meier analysis encompassing only malignant tumours showed similar results indicating that AREG is associated with astrocytoma patient survival independently from astrocytoma grade. 31031857 2019
CUI: C0006118
Disease: Brain Neoplasms
Brain Neoplasms
0.010 Biomarker group BEFREE AREG was also designated to be a promising marker for several types of cancer however precious little data about AREG role in the most frequent and generally lethal human brain tumours - astrocytomas reported up to date. 31031857 2019
CUI: C0008312
Disease: Primary biliary cirrhosis
Primary biliary cirrhosis
0.010 AlteredExpression disease BEFREE First, we demonstrated increased AREG levels in livers from patients with primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). 30411380 2019
CUI: C0008497
Disease: Choriocarcinoma
Choriocarcinoma
0.010 Biomarker disease BEFREE To explore the role of AREG in human choriocarcinoma cell proliferation. 31092430 2019
CUI: C0009324
Disease: Ulcerative Colitis
Ulcerative Colitis
0.010 Biomarker disease BEFREE Gastrointestinal amphiregulin was significantly lower in acute graft-versus-host disease biopsies (median score 1), ulcerative colitis (median score 1.5), and cytomegalovirus colitis (median score 1) than in normal colon (median score 2, p = 0.004, p = 0.03, p = 0.009 respectively). 30425334 2019
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.010 Biomarker group BEFREE Our results identify amphiregulin as a key player in injury-induced kidney fibrosis and suggest therapeutic or diagnostic applications of soluble amphiregulin in kidney disease. 31676723 2019
CUI: C0025202
Disease: melanoma
melanoma
0.010 AlteredExpression disease BEFREE We also found that the expression of amphiregulin, a member of the epidermal growth factor (EGF) family, was correlated with IL13Rα2 expression in cultured melanoma cells, xenograft tumour tissues and melanoma clinical samples. 30718742 2019
CUI: C0025286
Disease: Meningioma
Meningioma
0.010 AlteredExpression disease BEFREE For validation studies, we utilized an independent set of meningioma tumor tissue samples (Grade I, <i>n</i> = 20; Grade II, <i>n</i> = 10; Grade III, <i>n</i> = 6), and found that the expressions of amphiregulin and Caspase3 are significantly increased in all grades of meningiomas either at the transcriptional or protein level, respectively. 31649887 2019
CUI: C0027430
Disease: Nasal Polyps
Nasal Polyps
0.010 AlteredExpression disease BEFREE Increased TSLP, IL-33, IL-25, IL-19, IL 21 and amphiregulin (AREG) levels in chronic rhinosinusitis with nasal polyp. 30888496 2019
CUI: C0041956
Disease: Ureteral obstruction
Ureteral obstruction
0.010 Biomarker phenotype BEFREE Moreover, the finding that proximal tubule cell-specific amphiregulin knockout mice were protected from fibrosis after ischemia-reperfusion injury or unilateral ureteral obstruction demonstrates that amphiregulin was necessary for the development of fibrosis. 31676723 2019
CUI: C0085083
Disease: Ovarian Hyperstimulation Syndrome
Ovarian Hyperstimulation Syndrome
0.010 Biomarker disease BEFREE This study demonstrated that granulosa cell-secreted AREG plays an important role in the development of OHSS, suggesting that the EGFR/HER2-mediated signaling could be a novel drug target for the prevention and treatment of OHSS. 31167229 2019
CUI: C0151650
Disease: Renal fibrosis
Renal fibrosis
0.010 Biomarker disease BEFREE Proximal Tubule-Derived Amphiregulin Amplifies and Integrates Profibrotic EGF Receptor Signals in Kidney Fibrosis. 31676723 2019
CUI: C0267026
Disease: Actinic cheilitis
Actinic cheilitis
0.010 AlteredExpression disease BEFREE AC conditioned media from older lymphocytes had decreased levels of amphiregulin (367 ± 208 pg/mL vs 904 ± 323 pg/mL; p = .018) and IGF-I (845 ± 88 ng/mL vs 1100 ± 48 ng/mL; p = .032) compared with younger AC lymphocytes. 30329021 2019
CUI: C0278877
Disease: Adult Meningioma
Adult Meningioma
0.010 AlteredExpression disease BEFREE For validation studies, we utilized an independent set of meningioma tumor tissue samples (Grade I, <i>n</i> = 20; Grade II, <i>n</i> = 10; Grade III, <i>n</i> = 6), and found that the expressions of amphiregulin and Caspase3 are significantly increased in all grades of meningiomas either at the transcriptional or protein level, respectively. 31649887 2019
CUI: C0334579
Disease: Anaplastic astrocytoma
Anaplastic astrocytoma
0.010 AlteredExpression disease BEFREE GBM tissue disclosed elevated AREG mRNA expression but reduced AREG protein level as compared to grade II and grade III astrocytomas (p<0.001). 31031857 2019
CUI: C0341335
Disease: Cytomegaloviral colitis
Cytomegaloviral colitis
0.010 Biomarker disease BEFREE Gastrointestinal amphiregulin was significantly lower in acute graft-versus-host disease biopsies (median score 1), ulcerative colitis (median score 1.5), and cytomegalovirus colitis (median score 1) than in normal colon (median score 2, p = 0.004, p = 0.03, p = 0.009 respectively). 30425334 2019
CUI: C0521857
Disease: Increased drug resistance
Increased drug resistance
0.010 Biomarker phenotype BEFREE Pretreatment with exogenous recombinant AREG markedly increased drug resistance against VCR in OSCC cells, as assessed by an MTT assay. 31485602 2019
CUI: C0566602
Disease: Primary sclerosing cholangitis
Primary sclerosing cholangitis
0.010 AlteredExpression disease BEFREE First, we demonstrated increased AREG levels in livers from patients with primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). 30411380 2019
CUI: C0853879
Disease: Invasive carcinoma of breast
Invasive carcinoma of breast
0.010 Biomarker disease BEFREE Research is lacking on the role of AREG in invasive breast cancer and the co-expression with androgen receptor (AR) status. 31040043 2019
CUI: C0948008
Disease: Ischemic stroke
Ischemic stroke
0.010 Biomarker disease BEFREE The present study demonstrated that miR-449a was downregulated while AREG was upregulated in cerebral ischemic injury, and the recovery of neurological function can be obtained following the overexpression of miR-449a and the knockdown of AREG in an I/R injury model. miR-449a functions in ischemic stroke via directly targeting AREG. 30773606 2019
Meningioma, benign, no ICD-O subtype
0.010 AlteredExpression disease BEFREE For validation studies, we utilized an independent set of meningioma tumor tissue samples (Grade I, <i>n</i> = 20; Grade II, <i>n</i> = 10; Grade III, <i>n</i> = 6), and found that the expressions of amphiregulin and Caspase3 are significantly increased in all grades of meningiomas either at the transcriptional or protein level, respectively. 31649887 2019
CUI: C1840264
Disease: IMMUNE SUPPRESSION
IMMUNE SUPPRESSION
0.010 Biomarker phenotype BEFREE In light of these findings, we discuss whether, by locally activating TGFβ, T<sub>reg</sub> -derived Amphiregulin may contribute to both wound repair and immune suppression. 30866049 2019